| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Adam Schayowitz | EVP;Head | 2026-10-09 | 13,832 | $25.85 | $357.56kSell |
| Mark Hollywood | EVP Chief Operating Officer | 2026-07-06 | 939 | $22.22 | $20.86kBuy |
| Paul Andrew Moore | Chief Scientific Officer | 2026-01-12 | 9,560 | $22.67 | $216.76kSell |
| Kenneth Galbraith | Chair CEO | 2026-01-12 | 30,424 | $22.67 | $689.83kSell |
| Mark Hollywood | EVP Chief Operating Officer | 2026-01-12 | 6,120 | $22.67 | $138.76kSell |
| Jeffrey T. L. Smith | EVP Chief Medical Officer | 2026-01-12 | 9,310 | $22.67 | $211.09kSell |
| Leone D. Patterson | EVP Chief Bus Fin Officer | 2026-01-06 | 459 | $10.55 | $4.84kBuy |
| Paul Andrew Moore | Chief Scientific Officer | 2026-01-05 | 9,289 | $25.10 | $233.13kSell |
| Kenneth Galbraith | Chair CEO | 2026-01-05 | 22,657 | $25.10 | $568.62kSell |
| Kenneth Galbraith | Chair CEO | 2026-01-05 | 31,686 | $25.10 | $795.22kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ecor1 Capital LLC | 56.97% | 40,426,434 | $1.20B | Insider |
| Oleg Nodelman | 22.15% | 15,720,161 | $465.79M | Insider |
| Redmile Group LLC | 8.52% | 6,045,437 | $179.13M | Insider |
| Lilly Co Eli | 2.57% | 1,827,101 | $54.14M | Insider |
| Baker Bros Advisors LP | 2.17% | 1,540,220 | $45.64M | Insider |
| Ali Tehrani | 0.45% | 315,836 | $9.36M | Insider |
| Kenneth Galbraith | 0.32% | 226,842 | $6.72M | Insider |
| Nick Bedford | 0.19% | 137,223 | $4.07M | Insider |
| Mark Hollywood | 0.19% | 133,852 | $3.97M | Insider |
| Gregory Austin Ciongoli | 0.11% | 78,500 | $2.33M | Insider |